Abstract #295525 A phase 2 open-label, multicenter, study to evaluate the efficacy and safety of rivoceranib in subjects with recurrent or metastatic adenoid cystic carcinoma

Hyunseok Kang, Alan Loh Ho, Jameel Muzaffar, Daniel W Bowles, Sung-Bae Kim, Myung-Ju Ahn, Glenn J Hanna, Francis P Worden, Tak Yun, Steven Norton, Neil Sankar & Bhumsuk Keam
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.